ArticleScientific reports2019

HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinoma.

Kara S Meister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.